California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...
Prescriptions for the insulin glargine biosimilar Semglee increased after it was granted interchangeable status with its reference product, Lantus. Increases were seen across retail, mail order, and ...
SACRAMENTO, Calif. — California is capping the price of insulin to help the millions of Californians diagnosed with diabetes. Governor Gavin Newsom signed a new law that will limit copays for a 30-day ...
Hosted on MSN
My Experience Taking Insulin
Larry talks about the impact insulin had on him. Two arrests in Louvre jewel heist case ‘Glorifying Hitler’: Behind Ye’s visa snub Aussie obliterates American GOAT Ledecky's world record Golden ...
This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin—a critical hormone that regulates blood sugar in the body. Scientists at Scripps ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." A new scientific paper has a name for a different type of diabetes: type 5 diabetes. This form was ...
Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ ...
In an expansion of its previous moves to cut insulin prices, Sanofi will cap the price of each of its insulin products at $35 per month in the U.S. regardless of a patient's insurance status. The move ...
Glooko is looking to expand its diabetes treatment platforms to the inpatient setting, with a plan to acquire Monarch Medical Technologies and its EndoTool software for managing insulin doses within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback